Omkar Pharmachem Live BSE/NSE | Omkar Pharmachem Fundamenta data | Omkar Pharmachem Balance sheet | Omkar Pharmachem Quarterly Results | Omkar Pharmachem Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

19.06
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

19.88
N/A
2.27

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.79
10.76
-3.58

PAT CAGR (%)

10 Years
5 Years
3 Years

15.79
16.72
-

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

2.11
2.11
2.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-28.67
-65.49
-72.37

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.05 0.00 0.00 0.05 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00
Expenses 0.06 0.05 20.00% 0.08 0.10 -20.00% 0.06 0.14 -57.14% 0.05 0.06 -16.67%
EBITDA -0.01 -0.05 - -0.03 -0.10 - -0.01 -0.14 - -0.05 -0.06 -
EBIDTM -22.22% 0.00% -68.89% 0.00% -24.44% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.04 25.00% 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.01 -0.05 - -0.03 -0.10 - -0.07 -0.18 - -0.05 -0.06 -
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.01 -0.05 - -0.03 -0.10 - -0.07 -0.18 - -0.05 -0.06 -
PATM -22.22% 0.00% -68.89% 0.00% -144.44% 0.00% 0.00% 0.00%
EPS -0.01 -0.05 - -0.03 -0.10 - -0.06 -0.18 - -0.05 -0.06 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 0.15 0.05 0.00 0.00 0.00 0.00 0.00 0.07 0.06 0.07 0.00 Net Sales Growth 0.00% 0 0 0 0 0 -100% 16.67% -14.29% 0 Cost Of Goods Sold 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 0.14 0.05 0.00 0.00 0.00 0.00 0.00 0.07 0.06 0.07 0.00 GP Margin 90.00% 100% 0 0 0 0 0 100% 100% 100% 0 Total Expenditure 0.25 0.25 0.38 0.24 0.22 0.12 0.06 0.07 0.07 0.07 0.06 Power & Fuel Cost - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0 0 0 0 0 0% 0% 0% 0 Employee Cost - 0.15 0.19 0.14 0.14 0.03 0.02 0.02 0.04 0.03 0.03 % Of Sales - 300% 0 0 0 0 0 28.57% 66.67% 42.86% 0 Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0 0 0 0 0 0% 0% 0% 0 General & Admin Exp. - 0.09 0.11 0.09 0.08 0.08 0.03 0.04 0.03 0.03 0.03 % Of Sales - 180.0% 0 0 0 0 0 57.14% 50.0% 42.86% 0 Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0 0 0 0 0 0% 0% 0% 0 Miscellaneous Exp. - 0.00 0.08 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0 0 0 0 0 0% 0% 0% 0 EBITDA -0.10 -0.20 -0.38 -0.24 -0.22 -0.12 -0.06 0.00 -0.01 0.00 -0.06 EBITDA Margin -66.67% -400% 0 0 0 0 0 0% -16.67% 0% 0 Other Income 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 Interest 0.05 0.05 0.04 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBT -0.16 -0.26 -0.42 -0.25 -0.21 -0.12 -0.06 0.00 -0.01 0.00 -0.06 Tax 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 18.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -0.16 -0.26 -0.42 -0.26 0.22 -0.12 -0.06 0.00 -0.01 0.00 -0.06 PAT before Minority Interest -0.16 -0.26 -0.42 -0.26 0.22 -0.12 -0.06 0.00 -0.01 0.00 -0.06 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -106.67% -520.0% 0 0 0 0 0 0% -16.67% 0% 0 PAT Growth 0.00% 38.10% -61.54% -218.18% 283.33% -100% 0 100% 0 100% Unadjusted EPS -0.16 -0.26 -0.42 -0.26 0.22 -0.12 -0.06 0.00 -0.01 0.00 -0.06

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

0.15

0.05

0.00

0.07

0.06

0.07

0.00

Net Sales Growth

0.00%

-100%

16.67%

-14.29%

Cost Of Goods Sold

0.01

0.00

Gross Profit

0.14

0.05

0.00

0.07

0.06

0.07

0.00

GP Margin

90.00%

100%

Total Expenditure

0.25

0.38

0.24

0.22

0.12

0.06

0.07

0.06

Power & Fuel Cost

0.00

% Of Sales

Employee Cost

0.15

0.19

0.14

0.03

0.02

0.04

0.03

% Of Sales

300%

28.57%

66.67%

42.86%

Manufacturing Exp.

0.00

% Of Sales

General & Admin Exp.

0.09

0.11

0.09

0.08

0.03

0.04

0.03

% Of Sales

180.0%

57.14%

50.0%

42.86%

Selling & Distn. Exp.

0.00

% Of Sales

Miscellaneous Exp.

0.00

0.08

0.00

0.01

0.00

% Of Sales

EBITDA

-0.10

-0.20

-0.38

-0.24

-0.22

-0.12

-0.06

0.00

-0.01

0.00

-0.06

EBITDA Margin

-66.67%

-400%

-16.67%

Other Income

0.00

0.01

0.00

Interest

0.05

0.04

0.01

0.00

Depreciation

0.00

PBT

-0.16

-0.26

-0.42

-0.25

-0.21

-0.12

-0.06

0.00

-0.01

0.00

-0.06

Tax

0.00

0.05

0.00

Tax Rate

0.00%

18.52%

0.00%

PAT

-0.16

-0.26

-0.42

-0.26

0.22

-0.12

-0.06

0.00

-0.01

0.00

-0.06

PAT before Minority Interest

-0.16

-0.26

-0.42

-0.26

0.22

-0.12

-0.06

0.00

-0.01

0.00

-0.06

Minority Interest

0.00

PAT Margin

-106.67%

-520.0%

-16.67%

PAT Growth

0.00%

38.10%

-61.54%

-218.18%

283.33%

-100%

100%

Unadjusted EPS

-0.16

-0.26

-0.42

-0.26

0.22

-0.12

-0.06

0.00

-0.01

0.00

-0.06

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 8.44 8.70 9.12 9.38 9.16 9.27 9.34 9.33 9.34 9.35 Share Capital 10.08 10.08 10.08 10.08 10.08 10.08 10.08 10.08 10.08 10.08 Total Reserves -1.64 -1.38 -0.96 -0.71 -0.93 -0.81 -0.75 -0.75 -0.74 -0.74 Non-Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 0.92 0.62 0.28 0.05 0.56 0.12 0.10 0.12 0.11 0.06 Trade Payables 0.03 0.02 0.02 0.03 0.04 0.02 0.01 0.01 0.01 0.03 Other Current Liabilities 0.02 0.02 0.02 0.02 0.51 0.10 0.09 0.09 0.09 0.02 Short Term Borrowings 0.87 0.58 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.02 0.01 0.01 Total Liabilities 9.36 9.32 9.40 9.43 9.72 9.40 9.45 9.46 9.46 9.42 Net Block 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 Gross Block 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Accumulated Depreciation 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Assets 9.30 9.30 9.31 9.31 9.31 9.31 9.31 9.31 9.31 9.32 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 9.30 9.30 9.30 9.30 9.30 9.30 9.30 9.30 9.30 9.31 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 0.06 0.02 0.09 0.13 0.41 0.09 0.14 0.15 0.15 0.10 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 0.02 0.00 0.07 0.07 0.07 0.07 0.07 0.10 0.07 0.07 Cash & Bank 0.04 0.02 0.02 0.05 0.33 0.00 0.05 0.03 0.07 0.02 Other Current Assets 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 Short Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 Net Current Assets -0.86 -0.60 -0.19 0.07 -0.16 -0.03 0.03 0.03 0.04 0.03 Total Assets 9.36 9.32 9.40 9.44 9.72 9.40 9.45 9.46 9.46 9.42

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

8.44

8.70

9.12

9.38

9.16

9.27

9.34

9.33

9.34

9.35

Share Capital

10.08

Total Reserves

-1.64

-1.38

-0.96

-0.71

-0.93

-0.81

-0.75

-0.74

Non-Current Liabilities

0.00

0.01

Secured Loans

0.00

Unsecured Loans

0.00

0.01

Long Term Provisions

0.00

Current Liabilities

0.92

0.62

0.28

0.05

0.56

0.12

0.10

0.12

0.11

0.06

Trade Payables

0.03

0.02

0.03

0.04

0.02

0.01

0.03

Other Current Liabilities

0.02

0.51

0.10

0.09

0.02

Short Term Borrowings

0.87

0.58

0.24

0.00

Short Term Provisions

0.00

0.01

0.00

0.02

0.01

Total Liabilities

9.36

9.32

9.40

9.43

9.72

9.40

9.45

9.46

9.42

Net Block

0.00

0.01

0.00

0.01

Gross Block

0.01

Accumulated Depreciation

0.01

0.00

Non Current Assets

9.30

9.31

9.32

Capital Work in Progress

0.00

Non Current Investment

9.30

9.31

Long Term Loans & Adv.

0.00

Other Non Current Assets

0.00

Current Assets

0.06

0.02

0.09

0.13

0.41

0.09

0.14

0.15

0.10

Current Investments

0.00

Inventories

0.00

Sundry Debtors

0.02

0.00

0.07

0.10

0.07

Cash & Bank

0.04

0.02

0.05

0.33

0.00

0.05

0.03

0.07

0.02

Other Current Assets

0.00

0.01

0.00

Short Term Loans & Adv.

0.00

0.01

0.00

Net Current Assets

-0.86

-0.60

-0.19

0.07

-0.16

-0.03

0.03

0.04

0.03

Total Assets

9.36

9.32

9.40

9.44

9.72

9.40

9.45

9.46

9.42

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -0.21 -0.30 -0.25 -0.77 0.34 -0.05 0.02 -0.03 -0.04 -0.07 PBT -0.26 -0.42 -0.25 -0.21 -0.12 -0.06 0.00 -0.01 0.00 -0.06 Adjustment 0.06 0.12 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Changes in Working Capital -0.01 0.01 -0.01 -0.51 0.46 0.01 0.01 -0.02 -0.03 -0.01 Cash after chg. in Working capital -0.21 -0.30 -0.25 -0.73 0.34 -0.05 0.02 -0.03 -0.04 -0.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -0.05 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.00 0.00 -0.01 0.49 0.00 0.00 0.00 0.00 0.08 0.07 Net Fixed Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 Others 0.00 0.00 -0.01 0.49 0.00 0.00 0.00 0.00 0.07 0.00 Cash from Financing Activity 0.24 0.30 0.23 0.01 -0.01 0.00 0.00 0.00 0.00 0.00 Net Cash Inflow / Outflow 0.02 0.00 -0.03 -0.28 0.33 -0.05 0.02 -0.03 0.04 0.00 Opening Cash & Equivalents 0.02 0.02 0.05 0.33 0.00 0.05 0.03 0.07 0.02 0.02 Closing Cash & Equivalent 0.04 0.02 0.02 0.05 0.33 0.00 0.05 0.03 0.07 0.02

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-0.21

-0.30

-0.25

-0.77

0.34

-0.05

0.02

-0.03

-0.04

-0.07

PBT

-0.26

-0.42

-0.25

-0.21

-0.12

-0.06

0.00

-0.01

0.00

-0.06

Adjustment

0.06

0.12

0.02

0.00

Changes in Working Capital

-0.01

0.01

-0.01

-0.51

0.46

0.01

-0.02

-0.03

-0.01

Cash after chg. in Working capital

-0.21

-0.30

-0.25

-0.73

0.34

-0.05

0.02

-0.03

-0.04

-0.07

Interest Paid

0.00

Tax Paid

0.00

-0.05

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

0.00

-0.01

0.49

0.00

0.08

0.07

Net Fixed Assets

0.00

Net Investments

0.00

0.01

0.07

Others

0.00

-0.01

0.49

0.00

0.07

0.00

Cash from Financing Activity

0.24

0.30

0.23

0.01

-0.01

0.00

Net Cash Inflow / Outflow

0.02

0.00

-0.03

-0.28

0.33

-0.05

0.02

-0.03

0.04

0.00

Opening Cash & Equivalents

0.02

0.05

0.33

0.00

0.05

0.03

0.07

0.02

Closing Cash & Equivalent

0.04

0.02

0.05

0.33

0.00

0.05

0.03

0.07

0.02

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 8.37 8.63 9.05 9.30 9.08 9.20 9.26 9.25 9.27 9.27 ROA -2.78% -4.49% -2.72% 2.30% -1.22% -0.65% 0.04% -0.13% -0.02% -0.64% ROE -3.03% -4.72% -2.77% 2.38% -1.27% -0.66% 0.04% -0.13% -0.02% -0.64% ROCE -2.22% -4.11% -2.55% 2.91% -1.27% -0.66% 0.04% -0.13% -0.02% -0.64% Fixed Asset Turnover 3.69 0.00 0.00 0.00 0.00 0.00 6.27 5.42 5.87 0.00 Receivable days 146.00 0.00 0.00 0.00 0.00 0.00 464.39 537.08 418.69 0.00 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 62.69 37.45 63.30 97.57 348.66 173.49 123.25 71.81 171.15 450.77 Cash Conversion Cycle 83.31 -37.45 -63.30 -97.57 -348.66 -173.49 341.13 465.26 247.54 -450.77 Total Debt/Equity 0.10 0.07 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover -3.87 -10.25 -17.44 1769.77 -279.89 -722.95 24.37 -70.61 -6.31 -306.39

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

8.37

8.63

9.05

9.30

9.08

9.20

9.26

9.25

9.27

ROA

-2.78%

-4.49%

-2.72%

2.30%

-1.22%

-0.65%

0.04%

-0.13%

-0.02%

-0.64%

ROE

-3.03%

-4.72%

-2.77%

2.38%

-1.27%

-0.66%

0.04%

-0.13%

-0.02%

-0.64%

ROCE

-2.22%

-4.11%

-2.55%

2.91%

-1.27%

-0.66%

0.04%

-0.13%

-0.02%

-0.64%

Fixed Asset Turnover

3.69

0.00

6.27

5.42

5.87

0.00

Receivable days

146.00

0.00

464.39

537.08

418.69

0.00

Inventory Days

0.00

Payable days

62.69

37.45

63.30

97.57

348.66

173.49

123.25

71.81

171.15

450.77

Cash Conversion Cycle

83.31

-37.45

-63.30

-97.57

-348.66

-173.49

341.13

465.26

247.54

-450.77

Total Debt/Equity

0.10

0.07

0.03

0.00

Interest Cover

-3.87

-10.25

-17.44

1769.77

-279.89

-722.95

24.37

-70.61

-6.31

-306.39

Omkar Pharmachem Ltd.

Pharmaceuticals & Drugs

BSE: 532167 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Omkar Pharmachem Ltd.

Pharmaceuticals & Drugs

BSE: 532167 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update